Oral vaccine market to reach $6.29 billion by 2030 at 9.7% cagr, driven by rising prevalence of infectious diseases.
Read More
Oral transmucosal drugs market to reach $63.76 billion by 2030 at 7.8% cagr, driven by rising incidence of parkinson’s disease.
Read More
Oral solid dosage pharmaceutical formulation market to reach $846.38 billion by 2030 at 5.2% cagr, driven by increasing prevalence of chronic diseases.
Read More
Oral rehydration solution market to reach $6.92 billion by 2030 at 9.4% cagr, driven by increasing incidence of diarrheal diseases.
Read More
Oral proteins and peptides market to reach $4.26 billion by 2030 at 22.2% cagr, driven by growing biopharmaceutical industry.
Read More
Oral mucositis treatment market to reach $3.44 billion by 2030 at 9.9% cagr, driven by increasing use of chemotherapy.
Read More
Oral hypoglycemic agents market to reach $75.62 billion by 2030 at 4.9% cagr, driven by rise in type 2 diabetes prevalence.
Read More
Oral contraceptive pills market to reach $61.05 billion by 2030 at 15.0% cagr, driven by rising healthcare expenditure.
Read More
Oral clinical nutrition supplement market to reach $18.2 billion by 2030 at 6.6% cagr, driven by growing awareness of preventive healthcare.
Read More
Oral biologics & biosimilars market to reach $24.69 billion by 2030 at 21.6% cagr, driven by rising prevalence of chronic diseases.
Read More